This case report has a good side: the patient did get diagnosed and treated. But that only follows the dreadful treatment - missing cause of high cholesterol, took statins, rhabdomyolysis, kidney injury.
Claims to have been reversed. (I'd like to see the patient's opinion!) But questionable whether even one month of such suffering can be dismissed, pretty much, as one of those things.
It is obviously far more sensible to run at least TSH/FT4/FT3 before prescribing statins. Indeed, in my view, that should be mandatory.
The case report just comes across as too gung ho. Too "see how amazing we are". Even the title overclaims.
Case report: Rhabdomyolysis and kidney injury in a statin-treated hypothyroid patient-kill two birds with one stone.
Chiang WF 1, 2 , Chan JS 1, 2 , Hsiao PJ 1, 2 , Lin SH 2
Frontiers in Medicine, 10 Nov 2022, 9:1046330
DOI: 10.3389/fmed.2022.1046330 PMID: 36438056 PMCID: PMC9684604Share this article
Abstract
Statin treatment for hypercholesterolemia may cause reversible rhabdomyolysis and acute kidney injury in susceptible patients. However, persistent rhabdomyolysis and acute kidney injury following discontinuation of statins require careful evaluation of the underlying causes to avoid missing a curable disease. We describe a 50-year-old woman with hypercholesterolemia [total cholesterol 345 mg/dl, low-density lipoprotein cholesterol (LDL-C) 266 mg/dL] on atorvastatin therapy (40 mg daily) for 1 month that presented with myalgia and muscle weakness. Relevant laboratory studies revealed persistent higher hypercholesterolemia with total cholesterol (312 mg/dL), high creatine kinase (CK) (5,178 U/L), and high creatinine levels (1.5 mg/dL) without dysmorphic red blood cells and proteinuria. Despite the cessation of statin therapy, serum CK level increased to 9,594 U/L, and creatinine remained at 1.5 mg/dL. A thorough work-up to assess potential underlying causes indicated low T3 and free T4 and high thyroid-stimulating hormone (TSH) levels, consistent with hypothyroidism. With aggressive thyroxine replacement for 1 month, all of the clinical features, along with elevated serum CK and creatinine levels, were completely resolved. This case highlights the fact that hypothyroidism must be kept in mind as a potential cause of concomitant myopathy and kidney injury, especially in patients with statin-resistant hypercholesterolemia.